Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 3,154 | 3,458 | 1,143 | 0 | 0 |
| Gross Profit | 3,154 | 3,458 | 1,143 | N/A | N/A |
| Operating Expenses | 48,197 | 40,228 | 39,839 | 23,234 | 7,658 |
| Operating Income | -45,043 | -36,769 | -38,697 | -23,234 | -7,658 |
| Other Income | 464 | 483 | 541 | 0 | 0 |
| Pre-tax Income | -44,579 | -36,287 | -38,155 | -23,234 | -7,658 |
| Income Tax | 206 | 413 | 825 | N/A | N/A |
| Net Income Continuous | -44,785 | -36,699 | -38,980 | -23,234 | -7,658 |
| Net Income | $-44,785 | $-36,699 | $-38,980 | $-23,234 | $-7,658 |
| EPS Basic Total Ops | -1.56 | -1.66 | -1.94 | -2.16 | -1.03 |
| EPS Basic Continuous Ops | -1.56 | -1.67 | -1.94 | -2.16 | -1.03 |
| EPS Diluted Total Ops | -1.56 | -1.66 | -1.94 | -2.16 | -1.03 |
| EPS Diluted Continuous Ops | -1.56 | -1.67 | -1.94 | -2.16 | -1.03 |
| EPS Diluted Before Non-Recurring Items | -1.56 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-43,901 | $-36,031 | $-37,937 | $-22,814 | $-7,456 |